Mycoplasma hyopneumoniae vaccine
US10668139B2 · kind B2 · utility
0Cited by
58References
28Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jan 16, 2019 |
| Grant date | Jun 2, 2020 |
| Priority date | — |
| Expiry date | Jan 16, 2039 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12N2770/10034
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
This invention provides a protein-A or protein-G treated Mycoplasma hyopneumoniae (M.hyo) antigen that is compatible with antigens from other swine pathogens, wherein the M.hyo antigen is an M.hyo culture supernatant.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.